Evidence map›Paper›PMID 25892657›Full record

ArticleThe journal of pain2015

Artemin Immunotherapy Is Effective in Preventing and Reversing Cystitis-Induced Bladder Hyperalgesia via TRPA1 Regulation.

Jennifer J DeBerry, Jami L Saloman, Brian K Dragoo, Kathryn M Albers, Brian M Davis

Open access · greenAbstract read
In one paragraph

Article in The journal of pain, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Role of TRPA1 in Tissue Damage and Kidney Disease.International journal of molecular sciences · 2021
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. GDNF, Neurturin, and Artemin Activate and Sensitize Bone Afferent Neurons and Contribute to Inflammatory Bone Pain.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jennifer J DeBerryDepartment of Neurobiology, University of Pittsburgh, Pittsburgh, Pennsylvania; Pittsburgh Center for Pain Research, University of Pittsburgh, Pittsburgh, Pennsylvania. Electronic address: jenjdeb@uab.edu.
Jami L SalomanDepartment of Neurobiology, University of Pittsburgh, Pittsburgh, Pennsylvania; Pittsburgh Center for Pain Research, University of Pittsburgh, Pittsburgh, Pennsylvania.
Brian K DragooPittsburgh Center for Pain Research, University of Pittsburgh, Pittsburgh, Pennsylvania.
Kathryn M AlbersDepartment of Neurobiology, University of Pittsburgh, Pittsburgh, Pennsylvania; Pittsburgh Center for Pain Research, University of Pittsburgh, Pittsburgh, Pennsylvania; Center for Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania.
Brian M DavisDepartment of Neurobiology, University of Pittsburgh, Pittsburgh, Pennsylvania; Pittsburgh Center for Pain Research, University of Pittsburgh, Pittsburgh, Pennsylvania; Center for Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania.
University of Pittsburgh · US

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
Digestive Diseases Training ProgramT32DK063922 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ARTEEL, GAVIN E, YADAV, DHIRAJ · 2003 to 2022
$5.2M
PRIMARY VISCERAL AFFERENTS IN PAINR01NS035790 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DAVIS, BRIAN M · 1997 to 2014
$5.1M
Training in the Neurobiology of Neurological DiseaseT32NS086749 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Omar El Gharbawie, REBECCA P SEAL · 2014 to 2026
$4.8M
NEUROTROPHINS MODULATE SENSORY DEVELOPMENT AND FUNCTIONR01NS033730 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ALBERS, KATHRYN MARIE · 1995 to 2014
$4.1M
Role of Growth Factors in Persistent PainR01NS031826 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DAVIS, BRIAN M · 1993 to 2011
$3.5M
Characterization and Plasticity of Visceral NociceptorsR01NS050758 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DAVIS, BRIAN M · 2005 to 2012
$2.6M
Role of Neurogenic Inflammation in Pancreatic CancerR01CA177857 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DAVIS, BRIAN M · 2013 to 2017
$2.1M
Optogenetic dissection of the functional properties of bladder afferent populationsK01DK101681 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DEBERRY, JENNIFER J · 2014 to 2018
$679k
Effects of Inflammation in a Mouse Model of Interstital CystitisF32DK094593 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DEBERRY, JENNIFER J · 2012 to 2012
$49k
NCATS NIH HHS UL1 TR000005NCI NIH HHS R01 CA177857NIDDK NIH HHS DK094593NIDDK NIH HHS F32 DK094593NIDDK NIH HHS K01 DK101681NIDDK NIH HHS T32 DK063922NINDS NIH HHS NS0050758NINDS NIH HHS NS033730NINDS NIH HHS R01 NS031826NINDS NIH HHS R01 NS033730NINDS NIH HHS R01 NS035790NINDS NIH HHS R01 NS050758NINDS NIH HHS T32 NS086749PHS HHS DKD101681
6 · The paper itself

Abstract

unlabelledInjury- or disease-induced artemin (ARTN) signaling can sensitize primary afferents and contribute to persistent pain. We demonstrate that administration of an ARTN neutralizing antibody, anti-artemin (α-ARTN), can block the development of, and reverse already established, bladder hyperalgesia associated with cyclophosphamide-induced cystitis in mice. We further demonstrate that α-ARTN therapy blocks upregulation of TRPA1, an ion channel contributing to persistent bladder pain during cyclophosphamide-induced cystitis, and decreases phospho-ERK1/2 immunoreactivity in regions of the spinal cord receiving bladder afferent input. Thus, α-ARTN is a promising novel therapeutic approach for treatment of bladder hyperalgesia that may be associated with interstitial cystitis/painful bladder syndrome, as well as cystitis associated with antitumor or immunosuppressive cyclophosphamide therapy. PERSPECTIVE: α-ARTN therapy effectively prevented and reversed ongoing bladder hyperalgesia in an animal model of cystitis, indicating its potential as an efficacious treatment strategy for ongoing bladder pain associated with interstitial cystitis/painful bladder syndrome.

Indexed as

AnimalsAntibodiesAntineoplastic Agents, AlkylatingCalciumChi-Square DistributionCholera ToxinCyclophosphamideCystitisDisease Models, AnimalExtracellular Signal-Regulated MAP KinasesFemaleGlial Cell Line-Derived Neurotrophic FactorMiceMice, Inbred C57BLNerve Growth FactorNerve Tissue ProteinsAntibodiesAntineoplastic Agents, AlkylatingArtn protein, mouseCalciumCholera ToxinCyclophosphamideExtracellular Signal-Regulated MAP KinasesGlial Cell Line-Derived Neurotrophic FactorNerve Growth FactorNerve Tissue ProteinsRNA, MessengerTransient Receptor Potential ChannelsTRPA1 Cation ChannelTrpa1 protein, mousearteminBladdercystitisgrowth factorpainTRPA1visceral

Identifiers

PMID25892657
PMCPMC4489144
OpenAlexW1963566296

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.